Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan Sells 8,640 Shares

Electromed, Inc. (NYSE:ELMD) Director Kathleen Skarvan sold 8,640 shares of the business’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $32.25, for a total transaction of $278,640.00. Following the completion of the sale, the director now directly owns 71,576 shares of the company’s stock, valued at $2,308,326. The trade was a 10.77 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Kathleen Skarvan also recently made the following trade(s):

• On Tuesday, February 18th, Kathleen Skarvan sold 38,954 shares of Electromed stock. The stock was sold at an average price of $29.28, for a total value of $1,140,573.12.

Electromed Stock Performance

NYSE ELMD opened at $27.97 on Friday. Electromed, Inc. has a one year low of $13.74 and a one year high of $35.56. The company has a 50-day simple moving average of $31.40 and a 200-day simple moving average of $25.26. The firm has a market capitalization of $239.42 million, a PE ratio of 37.29 and a beta of 0.33.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the company. B. Riley assumed coverage on Electromed in a report on Thursday. They set a “buy” rating and a $38.00 target price on the stock. StockNews.com cut Electromed from a “strong-buy” rating to a “buy” rating in a research note on Wednesday.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Russell Investments Group Ltd. acquired a new position in shares of Electromed in the 4th quarter valued at about $37,000. IFP Advisors Inc acquired a new position in shares of Electromed in the 4th quarter valued at about $59,000. Quantbot Technologies LP acquired a new position in shares of Electromed in the 4th quarter valued at about $99,000. Bank of America Corp DE boosted its holdings in shares of Electromed by 179.2% in the 4th quarter. Bank of America Corp DE now owns 4,004 shares of the company’s stock valued at $118,000 after buying an additional 2,570 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Electromed in the 4th quarter valued at about $119,000. 40.82% of the stock is owned by institutional investors and hedge funds.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.